Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: — 2018 Double Blind Clinical Trial | BudProfiles

Home

Studies

Cannabidiol (CBD) as an Adjunctive Therapy in Schi...

PositiveDouble Blind Clinical Trial2018

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Schizophrenia

Related Studies

Positive

Possible Anxiolytic Effects of Cannabidiol (CBD) Administration on Feline Responses to a Fear Response Test

2025·Animal Study -

Inconclusive

Recreational drugs repurposed for medicinal use—cannabis

2025·Review/Other

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

Positive

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances

2025·Laboratory Study -

Inconclusive

Critical Windows of Vulnerability: Behavioral Dysregulation After Prenatal vs. Adolescent THC Exposure

2025·Review/Other

Inconclusive

Role of Lupinus Arboreus Extract in Cannabis-Induced Psychotic Behaviors in Wistar Rats

2025·Animal Study -

Cannabinoids

CBDCannabidiol

Organ Systems

Mental/Emotional System

Study Details

Type: Double Blind Clinical Trial
Year: 2018
Study ID: #2018374